McLeod L, Mallya UG, Fox T, Zhao Y, Mordin M, Strober B. Psoriasis patients with PASI90 response achieve greater health-related quality of life improvements than those with PASI75 response. Poster presented at the SDPA 13th Annual Fall Dermatology Conference 2015; November 2015. Orlando, FL. Previously presented at the 23rd European Academy of Dermatology and Venereology Congress.